Sign In
Buy XLV
$162.55
-0.97 (-0.593%)
At Close: Jul 31, 2026
Is This the Right Time to Consider Healthcare ETFs?
12:01pm, Thursday, 21'st Aug 2025
XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.
Gill: We're at a real inflection point for healthcare
10:35am, Friday, 15'th Aug 2025
Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
07:21am, Thursday, 14'th Aug 2025
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December
Final Trades: Netflix, Wynn Resorts, Buckle and the XLV
01:49pm, Monday, 11'th Aug 2025
The Investment Committee give you their top stocks to watch for the second half.
Healthcare: Winning Sector ETF Amid Soft U.S. July Jobs Report
07:01am, Wednesday, 06'th Aug 2025
Healthcare led July job gains with 55,000 new positions, as most other U.S. sectors showed little to no growth. Tap ETFs like XLV and VHT.
Beyond Broad Healthcare: A Smarter Prescription for Growth
10:06am, Friday, 01'st Aug 2025
Investing in healthcare has long been a cornerstone of defensive, long-term growth strategies. It is, after all, a massive and expanding segment of the global economy.
Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector
02:06pm, Monday, 28'th Jul 2025
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
Managed care needs to improve to improve health care sector, says Mizuho's Jared Holz
03:12pm, Monday, 21'st Jul 2025
Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if there are any opportunity plays within.
Trump's deadline looms for Big Pharma companies facing new tariffs
03:30pm, Wednesday, 16'th Jul 2025
'The Big Money Show' panel discusses President Donald Trump's pharmaceutical tariff strategy.
XLV: Life Expectancy, Patents, And A Positive Outlook Will Pave The Way
09:09am, Wednesday, 16'th Jul 2025
The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients for longer periods. Investors pay low fees to hold XLV, since the expense rat
A Historic Opportunity For REIT Investors
08:15am, Monday, 14'th Jul 2025
Today's market reminds us of 1999 in many ways. REITs were hated. Tech was loved. But afterward, REITs strongly outperformed. Here's why it could happen again.
Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch
04:00pm, Wednesday, 09'th Jul 2025
Rick Ducat turns to the healthcare sector on today's options analysis. He starts with the SPDR Health Care ETF (XLV), noting the recent breakdown of a head and shoulders pattern and potential for both
House Passes Trump's "Big, Beautiful Bill": ETFs in Focus
02:00pm, Monday, 07'th Jul 2025
TSLW may face pressure as the "Big, Beautiful Bill" axed EV tax credits and slashed support for clean energy.
June Jobs Data Puts Focus on Healthcare ETFs & Stocks
07:01am, Monday, 07'th Jul 2025
June's solid jobs report, with 39K new roles in healthcare, may boost the outlook for ETFs like XLV, IHF, VHT and stocks like HCA, WELL, OHI.
XLV: The S&P 500's Most Discounted Sector? Uncover The Hidden Risk
02:06pm, Thursday, 03'rd Jul 2025
The healthcare segment, and therefore XLV, is, in terms of relative valuations, the most attractive earning-driven sector. The strong dissonance between earnings expectations and price decline highlig
